Cross-Sectional Study Of The Association Between Obesity And Subclinical Hypothyroidism
DOI:
https://doi.org/10.47750/pnr.2023.14.04.14Abstract
Background: Obesity is defined by Body Mass Index (BMI). The prevalence of obesity is rising globally. Its prevalence is more than 30% in the people of well-developed countries such as the United States. Cardiovascular diseases, malignancies, chronic respiratory illnesses, diabetes and obesity are non-communicable diseases (NCDs). Its prevalence is increasing in Pakistan
Study design: A cross-sectional study
Place and Duration: This study was conducted in Shifa International Hospital Islamabad Pakistan from March 2022 to March 2023
Methodology: This research contains a total of 150 people who were having a body mass index of more than 25 kg/m2All of the patients were between 18 years and 60 years. The past medical and drug history and clinical examination e.g vitals monitoring, BMI calculation, thyroid examination was performed on predesign questionnaire. Those participants who had CLD, CKD, or those who took statins or other lipid lowering drugs were excluded from study. Blood samples were taken from every participant for measurement of TSH, FT4, FT3
Results: Out of a total of 150 people,67 males and 83 were females. The mean age was 35 years.We noticed subclinical hypothyroidism in 15% of the study population
Conclusion: Subclinical hypothyroidism is highly prevalent in the obese population, especially in those with a body mass index (BMI) of more than 29 kg/m2